Slide

NEWS & PRESS


Newsletter Spotlight

Subscribe to Corden Connect

Subscribe to receive our newsletter and browse the articles below.

SUBSCRIBE


October 9, 2023

CDMO Financial Resilience Through Technology & Investment

Edition 3 / October 2023
Editorial > Financial Resilience Through Innovative Technology & Strategic Investment
October 9, 2023

Technology & Science Advisory Board Kickoff Meeting

Edition 3 / October 2023
TSAB > CordenPharma’s Technology & Science Advisory Board Meeting Kickoff
October 9, 2023

Drug Product Innovation Centre Optimizes APIs & OSD Formulations

Edition 3 / October 2023
Early-Phase Drug Products > Drug Product Innovation Centre Targets Optimal API Modifications & OSD Formulations
October 9, 2023

Meet CordenPharma at CPHI Barcelona, AAPS PharmSci 360 & Tides Europe in 2023

Edition 3 / October 2023
Meet CordenPharma at CPHI Barcelona, AAPS or Tides Europe
June 27, 2023

A Look Inside CordenPharma’s Global People Strategy

Edition 2 / June 2023
Editorial > People-Centred Culture: CordenPharma’s New Global People Strategy
June 27, 2023

CordenPharma Re-Enters Synthetic Oligonucleotide Manufacturing Space

Edition 2 / June 2023
Oligonucleotides Platforms > Never Say Never: CordenPharma Oligos Are Back!
June 27, 2023

Project AIRMAIL: Using AI for LNP Formulation of RNA & DNA Actives

Edition 2 / June 2023
Lipids & Carbohydrates Platforms > Project AIRMAIL – Artificial Intelligence In Drug Development: Machine Learning Algorithm For The LNP Formulation Of RNA & DNA Actives
June 27, 2023

CordenPharma Bergamo’s State-of-the-Art API Development Building

Edition 2 / June 2023
Timelapse Video > New API Development Building at CordenPharma Bergamo
February 27, 2023

CordenPharma CEO on Record CDMO Growth in 2022 & Expansion for 2023

Edition 1 / February 2023
Editorial > 2022-2023: A Continuation of Record Growth & Expansion
February 27, 2023

CordenPharma Sets Science-Based Emission Reduction Targets for Sustainability

Edition 1 / February 2023
Article > Sustainability Through Science-Based Targets
February 27, 2023

CordenPharma Expands Into GMP Lipid NanoParticle Formulation in Caponago

Edition 1 / February 2023
Article > CordenPharma Expands Into GMP Lipid NanoParticle Formulation
October 3, 2022

Corden Connect Editorial: Strategic Growth & Environmental Governance

Edition 3 / October 2022
Editorial > A New Chapter of Strategic Growth & Environmental Governance
October 3, 2022

Video Interview: CordenPharma’s New Private Equity Owners, Astorg

Edition 3 / October 2022
Video Interview > CordenPharma's New Private Equity Shareholders Astorg
October 3, 2022

Solid State Centre of Excellence Identifies Optimal Process Conditions for API Production

Edition 3 / October 2022
Article > CordenPharma’s New Centre of Excellence for Solid State
October 3, 2022

Increase Your Supply Chain Efficiency with Flow Chemistry Services

Edition 3 / October 2022
Animated Video > The Benefits of CordenPharma’s Flow Chemistry & Continuous Manufacturing Services